NCT00021983View on ClinicalTrials.gov

Immunotoxin Therapy in Treating Patients With Hairy Cell Leukemia

PHASE1CompletedINTERVENTIONAL
Timeline

Start Date

December 31, 1998

Conditions
Leukemia
Interventions
BIOLOGICAL

BL22 immunotoxin

Trial Locations (1)

20892-1182

Warren Grant Magnuson Clinical Center - NCI Clinical Studies Support, Bethesda

All Listed Sponsors
lead

National Cancer Institute (NCI)

NIH

NCT00021983 - Immunotoxin Therapy in Treating Patients With Hairy Cell Leukemia | Biotech Hunter | Biotech Hunter